Literature DB >> 26730063

Osteopontin Expression in Patients with Hepatolith.

Bum Soo Kim1, Sun Hyung Joo2, Sung Jig Lim3, Kwang Ro Joo4.   

Abstract

To investigate the role of osteopontin (OPN) in the formation of hepatolith, we have immunohistochemically studied the involvement of OPN in hepatolithiasis in the intrahepatic bile ducts and the intramural and extramural glands, and in stones. In our hospital, 17 hepatic resections for hepatolithiasis were carried out from June 2006 to October 2009. Immunohistochemistry was performed on 17 liver specimens with hepatolith and on 24 control liver specimens without hepatolith. We compared the osetopontin expression in the epithelia of the intrahepatic bile ducts and peribiliary glands or periglandular macrophages. Staining for OPN was positive in the cytoplasm of the epithelial cells of stone-containing intrahepatic bile ducts and the intramural and extramural glands, and in stones. But there were no significant differences between the hepatolithiasis group and the control group for the OPN immunoreactivity of the luminal surface of the epithelial cells of the intrahepatic bile ducts and intramural and extramural glands. The stone-containing intrahepatic bile ducts were infiltrated by macrophages that showed intense staining for OPN. The core and matrix of the stones showed OPN immunoreactivity. The degree of OPN from the cytoplasm of the epithelia of the intrahepatic bile ducts and peribiliary glands or periglandular macrophages was different between hepatolithiasis and control groups. Our result suggests that the OPN from the intrahepatic bile ducts and peribiliary glands plays a role in the formation of intrahepatic stone.

Entities:  

Keywords:  Hepatolithiasis; Immunohistochemistry; Intrahepatic bile duct; Osteopontin

Year:  2013        PMID: 26730063      PMCID: PMC4692876          DOI: 10.1007/s12262-013-0919-z

Source DB:  PubMed          Journal:  Indian J Surg        ISSN: 0973-9793            Impact factor:   0.656


  29 in total

1.  Intrahepatic gene expression in human alcoholic hepatitis.

Authors:  Devanshi Seth; Mark D Gorrell; Shaun Cordoba; Geoffrey W McCaughan; Paul S Haber
Journal:  J Hepatol       Date:  2006-06-05       Impact factor: 25.083

2.  Osteopontin expression in proliferated bile ductules: the correlation with liver damage in fulminant hepatitis.

Authors:  Takuma Tajiri; Genshu Tate; Toshiaki Kunimura; Yutaka Endo; Kazuaki Inoue; Toshiyuki Mitsuya; Toshio Morohoshi; Makoto Yoshiba
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

3.  Isolation of a calcium-regulatory protein from black pigment gallstones: similarity with a protein from cholesterol gallstones.

Authors:  M Okido; S Shimizu; J D Ostrow; F Nakayama
Journal:  Hepatology       Date:  1992-06       Impact factor: 17.425

4.  Ultrastructural immunogold localization of osteopontin in human gallbladder epithelial cells.

Authors:  L F Brown; D R Senger; L L Geng; H F Dvorak; A M Dvorak
Journal:  J Histochem Cytochem       Date:  1994-03       Impact factor: 2.479

Review 5.  The role of osteopontin in tumorigenesis and metastasis.

Authors:  A J Oates; R Barraclough; P S Rudland
Journal:  Invasion Metastasis       Date:  1997

Review 6.  Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers.

Authors:  Dong-Xing Cao; Zhi-Jie Li; Xiao-Ou Jiang; Yick Liang Lum; Ester Khin; Nikki P Lee; Guo-Hao Wu; John M Luk
Journal:  World J Gastroenterol       Date:  2012-08-14       Impact factor: 5.742

Review 7.  Intrahepatic peribiliary glands of humans. II. Pathological spectrum.

Authors:  Y Nakanuma; M Sasaki; T Terada; K Harada
Journal:  J Gastroenterol Hepatol       Date:  1994 Jan-Feb       Impact factor: 4.029

8.  Osteopontin is involved in the formation of epithelioid granuloma and bile duct injury in primary biliary cirrhosis.

Authors:  Kenichi Harada; Satoru Ozaki; Yoshiko Sudo; Koichi Tsuneyama; Hajime Ohta; Yasuni Nakanuma
Journal:  Pathol Int       Date:  2003-01       Impact factor: 2.534

9.  Microstructure of gallstones.

Authors:  J M Been; P M Bills; D Lewis
Journal:  Gastroenterology       Date:  1979-03       Impact factor: 22.682

10.  Identification of gallbladder mucin-bilirubin complex in human cholesterol gallstone matrix. Effects of reducing agents on in vitro dissolution of matrix and intact gallstones.

Authors:  B F Smith; J T LaMont
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

View more
  1 in total

Review 1.  Is Osteopontin a Friend or Foe of Cell Apoptosis in Inflammatory Gastrointestinal and Liver Diseases?

Authors:  Tomoya Iida; Kohei Wagatsuma; Daisuke Hirayama; Hiroshi Nakase
Journal:  Int J Mol Sci       Date:  2017-12-21       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.